Some biological actions of alkylglycerols from shark liver oil

Journal of Alternative and Complementary Medicine

Volumn 4, Issue 1, 1998, Pages 87-99

  Pugliese, Peter T ^a,d   Jordan, Karin ^b   Cederberg, Hokan ^b   Brohult, Johan ^c  

^a MD and Assoc   (United States)

^b Scandinavian Natural Products   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Peter T Pugliese MD Assoc Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; FISH OIL; GLYCEROL ETHER; PROTEIN KINASE C;

ANIMAL; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MACROPHAGE ACTIVATION; REVIEW; SECOND MESSENGER; SHARK; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; FISH OILS; GLYCERYL ETHERS; HUMANS; MACROPHAGE ACTIVATION; PROTEIN KINASE C; SECOND MESSENGER SYSTEMS; SHARKS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032017935     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.1998.4.1-87     Document Type: Review

References (77)

1. Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev Immunol 1984;2:283-318.
2. Adams DO, Hamilton TA. Molecular bases of signal transduction in macrophage activation induced by IFNY and by second signals. Immunol Rev 1987;97:1-27.
3. Andreesen R, Modelell ML, Weltzien HU, Common HH, Lori GW, Nlunder PG. Selective destruction of human leukemic cells by alkylysophospholipids. Cancer Res 1978;38:3894.
4. Bandi ZL, Mangold HK. Substrate specificity of enzymes catalyzing interconversions of long-chain acids and alcohols in the rat. FEBS Lett 1973;1:97-100.
5. Baumann WJ (ed) 1987 Ether lipids in Oncology, American Oil Chemists' Society Press, Champaign, IL.
6. Berdel WE, Bausert WR, Weltzien HU, Modelell ML, Widmann KH, Munder P. The influence of alkyllysophospholipids and lysophospholipids activated macrophages on the development of metastasis of Lewis lung carcinoma. Eur J Cancer 1980;16:1199.
7. Berdel WE, Fink U, Thiel E, Stinkel K, Greiner E, Schwarzkopf G, Reichert A Rastetter J Inhibition by alkyl-lysophospholipids of tritiated thymidine uptake in cells of human malignant urologic tumors. J Natl Cancer Inst 1982;66:813.
8. Berdel WE. Ether lipids and analogs in experimental cancer therapy. A brief review of the Munich experience. Lipids 1987;22:970-973.
9. Bergstrom S, Blomstrand R. The intestinal absorption and metabolism of chimyl alcohol in the rat. Acta Physiol Scand 1956;38:166.
10. Berridge MJ. Inositol trisphosphate and diacylglycerol as second messengers. Biochem J 1984;220:345-360.
11. Bianco C, Griffin FM, Silverstein SC. Studies of the macrophage complement receptors. Alteration of receptor function upon macrophage activation. J Exp Med 1975;141:1278.
12. Blank ML, Lee TC, Fitzgerald V, Snyder F. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem 1981;256:175-178.
13. Blomstrand R. Digestion, absorption and metabolism of chimyl alcohol fed as free alcohol or as alkyloxy-diglyceride. Proc Soc Exp Biol Med 1959;102:62-665.
14. Blomstrand R, Ahrens EH, Jr. Absorption of chimyl alcohol in man. Proc Soc Exp Biol Med 1959;100:802-805.
15. Bodman J, Maisin JH. The a-glyceryl ethers. Clin Chim Acta 1958;3:253.
16. Brachwitz H, Longen P, Arndt D, Fichtner I. Cytostatic activity of synthetic O-alkylglycerolipids. Lipids 1987; 22:897-903.
17. Brohult A. Alkoxyglycerols as growth-stimulating substances. Nature 1960;188:591-592.
18. Brohult A. Alkylglycerols and their use in radiation. Acta Radiologica (Suppl) 1963;223:7-99.
19. Brohult A, Brohult J, Brohult S, Joelsson I. Effect of alkoxyglycerols on the frequency of injuries following radiation therapy for carcinoma of the uterine cervix. Acta Obstet Gynecol Scand 1977;56:441-448.
20. Brohult A, Brohult J, Brohult S, Joelsson I. Reduced mortality in cancer patients after administration of alkoxyglycerols. Acta Obstet Gynecol Scand 1986;65:779-785.
21. Caldwell JE, Sifferd RH, Porsche JD, Fenger F. Recent studies on yellow bone marrow extracts. Am J Med Sci 1945;2:717.
22. Castagna M, Yoshima T, Kaibachi S, Kakkawa U, Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumour-promoting phorbol esters. J Biol Chem 1982;257: 7847-7851.
23. Cohn ZA. The macrophage - Versatile element of inflammation. Harvey Lect 1982;77:63.
24. Darnell J, Lodish H, Baltimore D 1990 Molecular Cell Biology. W.H. Freeman Company, New York, p. 742.
25. Das AK, Homes RD, Wilson GN, Hajra AK. Dietary ether lipid incorporation in tissue plasmalogens of humans and rodents. Lipids 1992;27:401-405.
26. Demopoulos CA, Pinckard RN, Hanahan DJ. Platelet-activating factor. Evidence for 1-O-alkylglyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 1979;254: 9355-9358.
27. Elsbach P 1977 Cell surface changes in phagocytosis. In Nicolson GL, Poste G (eds) Surface Reviews. North-Holland, Amsterdam. p. 363.
28. Ghys R. Effets des alkoxyglycerols (KabY 700) sur la leucopenie consecutive a la radiotherapie. Laval Mod 1960;30:331.
29. Hallgren B, Larsson S. The glyceryl ethers in the liver oils of elasmobrach fish. Lipid Res 1962;3:31-33.
30. Hallgren B, Larsson S. The glyceryl ethers in man and cow. J Lipid Res 1962b;3:39.
31. Hallgren B, Niclasson A, Ställberg G, Thorin H. On the occurrence of 1-O-alkylglycerols and 1-O-(2-methoxy alkyl) glycerols in human colostrum, human milk, cow's milk, sheep's milk, human red bone marrow, red cells, blood plasma and a uterine carcinoma. Acta Chem Scand 1974;B28:1029-1034.
32. Halliwell B, Gutteridge JC 1993 Free Radicals in Biology and Medicine. Clarendon Press, Oxford, p. 22.
33. Holmberg J, Mysen G, Persson G 1962 Component lipids of some food raw materials. Sixth Congress of the International Society for Fat Research, London.
34. Homma S, Yamamoto N. Activation process of macrophages after in vitro treat of mouse lymphocytes with dodecylglycerol. Clin Exp Immunol 1990;79:307-313.
35. Lee TC, Snyder F 1985 Function, metabolism, and regulation of platelet activating factor and related ether lipids. In Kuo JF (ed) Phospholipids and Cellular Regulation. CRC Press, Boca Raton, FL. pp. 1-39.
36. Lewis JC, O'Flaherty JT, McCall CE, Wykle RL, Bond MG. Platelet-activating factor effects on pulmonary ultra structure in rabbits. Exp Mol Pathol 1983;38:100-108.
37. Linman JW. Hemopoietic effects of glyceryl ethers. Inactivity of selachyl alcohol. Proc Soc Exp Biol Med 1960;104:703-706.
38. Mackaness GB 1970 The mechanisms of macrophage activation. In Mudd S (ed) Infectious Agents and Host Reactions. W.B. Saunders Co., Philadelphia, PA, pp. 61-75.
39. Marberg CM, Wikes HO 1937 Yellow bone marrow extracts in granulocytopenia. J Amer Med Assoc 1965; 109:1-39.
40. Marberg CM, Wikes HO. Granulocytopoietic fraction of yellow bone marrow, Arch Intern Med 1938;61:408.
41. McManus LM. Pathobiology of platelet-activating factor. Pathol Immunopathol Res 1986;5:104-117.
42. McNeely TB, Rosen G, Londner MV, Turco SJ. Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphospatidylinositol antigens of the protozoan parasite Leishmania. Biochem J 1989;259:601-604.
43. Mencia-Heurta JM, Raubin R, Benneviste J. Acetyl co-enzyme A and sodium acetate enhance the release of platelet-activating factor (PAF) from murine peritoneal cells. Int Arch Allergy Appl Immunol 1981;66:178-179.
44. Migliore-Samour D, Jolles P. Casein, a prohormone with an immunomodulating role for the newborn? Experientia 1988;44:188-193.
45. Modelell M, Andreesen R, Pahikes W, Brugger U, Munder PG. Disturbance of phospholipid metabolism during selective destruction of tumor cells induced by alkylphospholipids. Cancer Res 1979;38:4681.
46. Mulik N, Tosaki A, Engelman RM, Cordis GA, Das DK. Myocardial salvage by 1-O-hexadecyl-sn-glycerol: Possible role of peroxisomal dysfunction in ischemia reperfusion injury. J Cardiovasc Pharmacol 1994;24:486-492.
47. Murray HW 1986 Macrophage activation in the acquired immunodeficiency syndrome. In Steinman RM, North RJ (eds) Mechanisms of Host Resistance to Infectious Agents, Tumors and Allografts. Rockefeller University Press, New York., p. 333.
48. Nathan CF. Mechanisms of macrophage antimicrobial activity. Trans R Soc Trop Med Hyg 1983;77:620-630.
49. Nathan CF 1986a Interferon-gamma and macrophage activation in cell-mediated immunity. In Steinman RM, North RJ (eds) Mechanisms of Host Resistance to Infectious Agents, Tumors and Allografts. Rockefeller University Press, New York, pp. 165-184.
50. Nathan CF. Macrophage activation: Some questions. Ann Inst Pasteur 1986b;137C:345-351.
51. Nathan CN, Nogueira N, Juangbhanich C, Ellis J, and Cohn Z. Activation of macrophages in vivo and in vitro: Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi. J Exp Med 1979;149: 1056-1068.
52. Nathan CF, Tsunawaki S. Secretion of toxic oxygen products by macrophages: Regulatory cytokines and their effects on the oxidase. Ciba Found Symp II 1986;8:211-230.
53. Ngwenya BZ, Yamamoto N. Activation of peritoneal macrophages by lysophosphatidylcholine. Biochem Biophs Acta 1985;839:9-15.
54. Ngwenya BZ, Yamamoto N. Effects of inflammation products on immune systems: Lysophosphatidylcholine stimulates macrophages. Cancer Immunol Immunother 1986;21:174-182.
55. Nishizuka Y. Turnover of inositiol phospholipids and signal transduction. Science 1984;225:1365-1370.
56. O'Flaherty FA, Wylke RL. Biology and biochemistry of platelet-activating fator. Clin Rev Allergy 1983;1:353-367.
57. Oh S, Jadhav LS. Effects of dietary alkylglycerols in lactating rats on immune response. Pediatr Res 1994; 36:300-305.
58. Orga SS, Weintraub D, Orga PL. Immunologic aspects of human colosrum and milk. J Immunol 1977;19:245-248.
59. 2+ transporting membrane vesicle fraction derived from human platelets. J Biol Chem 1985;260:956-962.
60. Paltauf F. Metabolism of the enantiomeric 1-O-alkylglycerol ethers in the rat intestinal mucosa in vivo; incorporation into 1-O-alkyl and 1-O-alkyl-1-enyl glycerol lipids. Biochem Biophys Acta 1971;239:38-46.
61. Pinckard RN 1985 Platelet-activating factor. In: Kaplan AP (ed) Allergy. Churchill Livingstone, New York, pp. 165-174.
62. Quie PG. Antimicrobial defenses in the neonate. Semin Perinatol 1990;14:2-9.
63. Robinson M, Burdine R, Warne T. Inhibition of phorbol ester-stimulated arachidonic acid release by alkylglycerols. Biochim Biophys Acta 1996;1254:361-367.
64. Schlondorff D, Neuwirth R. Platelet-activating factor and the kidney. Am J Physiol 1986;251:FI-FI I.
65. Shparber M, Nathan CF. Autocrine activation of macrophages by recombinant tumor necrosis factor but not recombinant interleukin-1 [abstract]. Blood 1986;68 (suppl):86a.
66. Tsujimoto M. The liver oils of Elasmobranch fish. J Soc Chem Ind 1932;S1:317.
67. Tsujimoto M, Toyama Y. Uber die unverseifbaren Bestandteile (hoheren Alkohole) der Haifisch und Rochenleberole. Chem Umschau 1922;29:35.
68. Wardlow ML, Cox CP, Meng KE, Greene DE, Fair RS. Substrate specificity and partial characterization of the PAF-acylhydrolase in human serum that rapidly inactivates platelet-activating factor. J Immunol 1986;136: 3441-3446.
69. Warne TR, Buchanan FG, Robinson M. Growth-dependent accumulation of monoalkylglycerols in the Madin-Darby canine kidney cells. J Biol Chem 1995;19:11147-11154.
70. Watkins CV, Giffin HZ. Abstract of paper read to Sect. Pract. Med. of Am. Med. Ass. Published in its Science Program, 1933.
71. 14] dodecylglycerol and nutritional effect of dietary rac-1-O-dodecylglycerol in mice. J Lipid Res 1985; 26:1412-1420.
72. Weltzien HU, Munder PG 1983 In Mangold HK, Paltauf F (eds) Ether Lipids Biochemical and Biomedical Aspects Academic Press, New York, pp. 277-308.
73. Werbach MR. Alkylglycerols in cancer. J Orth Molec Med 1994;9:71.
74. Wykle RL, Olson C, O'Flaherty JT. Biochemical pathways of platelet-activating actor synthesis and breakdown. Adv Inflam Res 1986;11:71-81.
75. Yamamoto N, Ngwenya BZ, Sery TW, Pieringer RA. Activation of macrophages by ether analogues of lysophospholipids. Cancer Immunol Immunother 1987; 25:185.
76. Yamamoto D, Homma S, Haddad AM, Kowalski A. Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse perioneal cells. Immunology 1991;74:420-424.
77. Yamamoto N, St. Clair DA, Homma S, Nywenya B. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues. Cancer Res 1988;48:6044-6049.